Clinical Trial Update: Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluated omega-3 fatty acid supplementation in cervical cancer patients undergoing chemoradiotherapy, with sarcopenia as a condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Sarcopenia

Drugs mentioned

• Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Brazilian National Cancer Institute | Conditions: Sarcopenia | NA | Status: COMPLETED